lower waist size, blood pressure, and cholesterol) compared with those taking a placebo
My doctor was skeptical at first but the bloodwork speaks for itself
Diabetes is a progressive condition, and discontinuing effective glucose-lowering therapy typically results in deterioration of glycemic control
This happens because GLPs improve satiety, insulin-sensitivity and can decrease food noise, in the brain
In pathophysiological situations, as occurs in Zucker obese rats, exendin-4 seems to act as a compensator for the variations in AMPK activity produced either by oscillations in glucose levels or by pathologies such as obesity or episodes of hyperinsulinemia
Diabetes, Obesity and Metabolism, 24 (8), 1553-1564